BayWa’s Share Price Sinks 12% as Legal Woes Compound Renewable Unit Sale Setback

BayWa faces triple crisis: criminal probes, BaFin reprimand, and lowered BayWa r.e. sale outlook, sending stock down 11.8% as lenders give until autumn for restructuring.

Three separate fronts of pressure have converged on BayWa with unusual force, sending its stock sharply lower even as the underlying agricultural business posts operational improvements. The Munich-based conglomerate now stares down criminal investigations, a BaFin reprimand, and a drastically reduced outlook for the sale of its renewable-energy division BayWa r.e. — all while a standstill agreement with lenders buys only until autumn to finalise a revised restructuring plan.

The stock tumbled 11.79 percent on Tuesday to hit €12.35, bringing its year-to-date loss to 26.27 percent. The immediate trigger was growing scepticism over the expected proceeds from the planned disposal of 51 percent of BayWa r.e., long billed as the centrepiece of the group’s deleveraging strategy. Chief executive Marcus Baur acknowledged that the earlier target of €1.7 billion is no longer attainable, forcing management to recalibrate the entire rescue blueprint.

First-quarter revenue fell to €2.3 billion from €3.6 billion a year earlier, weighed down by the sale of stakes, weak construction activity, adverse weather, the Iran conflict, and customer uncertainty linked to negative reports about BayWa r.e. Yet on an operational basis, the picture is more nuanced: adjusted EBITDA came in ahead of both last year’s level and the internal targets set out in the restructuring plan. The group has also made tangible headroom on debt reduction: disposals of RWA, Cefetra, WHG, and EDL have cut bank liabilities by roughly €1.3 billion. Cefetra alone reduced debt by more than €600 million.

Still, the total mountain remains forbidding. BayWa aims to shrink net bank debt from €5.4 billion to around €1.3 billion by 2028, a reduction of €4 billion. Creditors are being asked to waive roughly €1 billion of that sum. The company also plans to eliminate about 1,300 jobs and pare annual revenue to €10 billion by the same deadline. The standstill agreement with its core lenders runs until the autumn, giving a narrow window to secure fresh commitments.

The legal dimension adds another layer of unpredictability. Munich prosecutors have opened investigations into former CEOs Klaus Josef Lutz and Marcus Pöllinger on suspicion of breach of trust and falsification of balance-sheet details, raiding several private homes in January. Both men deny the allegations through the presumption of innocence. At the same time, Germany’s financial watchdog BaFin issued a formal reprimand after BayWa omitted material information about a billion-euro loan and refinancing risks tied to a major bond in its 2023 annual report. The oversight body Apas is now scrutinising auditor PwC, which had given the financial statements an unqualified opinion. BayWa is examining potential damages claims against PwC and will put the audit contract out to tender from 2026.

A shareholder lawsuit is also in the works. Law firm TILP is preparing a class-action complaint against BayWa, former board members, and PwC on behalf of investors who held the stock between January 2022 and January 2026, alleging deception about the company’s financial health.

A court has reconstituted the supervisory board, installing three new managers with experience at Bayer, Wienerberger, and Lidl. The approval threshold for board-level transactions has been slashed from €200 million to €50 million, tightening oversight at a critical moment. The full 2025 annual report, initially expected in spring, has been pushed back to the fourth quarter of 2026 — specifically October 30 — leaving the bank negotiations without a certified set of numbers.

Analyst Rene Rückert of Baader Bank maintained his “Buy” rating, albeit with a price target of only €6. He argues that many of the restructuring risks are already priced into the stock, while cautioning that the overall situation remains exceptionally high-risk. With the revised plan due around mid-year and the standstill clock ticking, every euro from asset sales will count in the weeks ahead.